Robert J. Israel

Dehydroascorbic acid, a blood–brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke

Judy Huang, David B. Agus, Christopher J. Winfree et al. · Proceedings of the National Academy of Sciences · 2001 · 225 citations · Full text

Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study

Russell K. Portenoy, Michele L. Moehl Boatwright, Diep N. H. Tran et al. · Journal of Pain and Symptom Management · 2008 · 181 citations

Pain Medicine, Postoperative Pain Management, Pharmacology +9

Single‐Dose Safety, Pharmacology, and Antiviral Activity of the Human Immunodeficiency Virus (HIV) Type 1 Entry Inhibitor PRO 542 in HIV‐Infected Adults

Jeffrey M. Jacobson, Israel Lowy, Courtney V. Fletcher et al. · The Journal of Infectious Diseases · 2000 · 152 citations

Single‐dose Safety, Immunology, Pharmacotherapy +20

Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542

Jeffrey M. Jacobson, Robert J. Israel, Israel Lowy et al. · Antimicrobial Agents and Chemotherapy · 2004 · 123 citations

Viral Entry Inhibitors, Human Retrovirus, Immunology +13

Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.

Paul B. Chapman, Donna M. Morrissey, Katherine S. Panageas et al. · PubMed · 2000 · 103 citations

Immunology, Pathology, Immunotherapy +16